JPRN-jRCTs071180073已完成2 期
Further maintenance of remission for a year after Qing-Dai withdrawal in ulcerative colitis treatment:randomized controlled trial - None
Kitazono Takanari0 个研究点目标入组 21 人开始时间: 2019年3月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
The remission rate at 52 weeks after study enrolment in the continue group was significantly higher than in the discontinue group. Because the number of patients enrolled in the study was lower than predicted, it was difficult to continue the study.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Patients who undergo the treatment of Qing-Dai over a year
- •2) Patients whose disease activity is 1 or 0 by Mayo endoscopic score
- •3) Patients who received full-explanation and completely understood the study.
- •4) Patients with no change in treatment within the past 2 weeks before the commencement of the study
- •5) Patients with no change in treatment of ulcerative colitis during their oral administration of Qing-Dai
- •6) Patients who have voluntarily submitted written consent forms upon participation in this study
排除标准
- •1)Pregnant or breastfeeding women
- •2)Patients who have a history of psychosomatic disorders
- •3)Patients who have a history of liver or renal diseases
- •4)Patients who have a history of antithrombotic therapy or thrombocytopenia
- •5)Patients who have a history of hepatitis B
- •6)Patients whom investigators and subinvestigators considered inappropriate to participate in this study
研究者
相似试验
已完成
不适用
Further maintenance of remission for a year after Qing-Dai withdrawalin ulcerative colitis treatment:randomized controlled trialulcerative colitisJPRN-UMIN000028574Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University40
已完成
不适用
Further maintenance of remission for a year after infliximab withdrawal in ulcerative colitis treatment: a multicenter, controlled trial in Japaulcerative colitisJPRN-UMIN000012092Center for Clinical Research, Keio University School of Medicine250
已完成
4 期
Prospective observational study on efficacy and safety of PEGASYS/COPEGUS for non-responder/relapser to pegylated interferon or non pegylated interferon plus ribaviriChronic hepatitis CJPRN-UMIN000003709Chugai pharmaceutical CO., LTD.851
已完成
不适用
Continuation of Patient Follow-up to 2 Years for the Pinnacle RSA and Pinnacle DM RSA Clinical TrialsHip OsteoarthritisNCT05930067Canadian Radiostereometric Analysis Network82
已完成
3 期
INTERVENTION FOR IMPROVING TREATMENT ADHERENCE OF OUT-PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEchronic obstructive pulmonary disease (COPD)COPD, education intervention, treatment adherenceTCTR20240526001Vingroup Innovation Foundation (VINIF)90